Disturbance of circadian gene expression in hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 47, Issue 12, 2008, Pages 925-933

  Lin, Yueh Min ^a,b   Chang, Julia H ^a,b   Yeh, Kun Tu ^a,b   Yang, Ming Yu ^a,c   Liu, Ta Chih ^a   Lin, Sheng Fung ^a   Su, Wei Wen ^b   Chang, Jan Gowth ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d Taipei Institute of Pathology   (Taiwan)

Author keywords

Circadian genes; Hepatocellular carcinoma; Immunohistochemical study; Mutation analysis; Promoter methylation

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; METHYLATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CIRCADIAN RHYTHM; FEMALE; FLAVOPROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 56749176759     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20446     Document Type: Article

References (49)

1. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005;19:3-23.
2. Seeff LB, Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 2006;25:3771-3777.
3. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127:S87-S96.
4. Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene 2006;25:3778-3786.
5. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007;27:55-76.
6. Feitelson MA, Sun B, Tufan NLS, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002;21:2593-2604.
7. Thoreirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-346.
8. Scheving LA. Biological clocks and the digestive system. Gastroenterology 2000;119:536-549.
9. Keith LG, Oleszczuk JJ, Laguens M. Circadian rhythm chaos: A new breast caner marker. Int J Fertil 2001;46:238-247.
10. Fu L, Lee CC. The circadian clock: Pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350-361.
11. Wager-Smith K, Kay SA. Circadian rhythm genetics: From files to mice to humans. Nat Genet 2000;26:23-27.
12. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002;418:935-941.
13. Yamaguchi S, Isejima H, Matsuo T, et al. Synchronization of cellular clocks in the suprachiasmatic nucleus. Science 2003;302:1408-1412.
14. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res 2002;309:193-199.
15. Stratmann M, Schibler U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J Biol Rhythms 2006;21:494-506.
16. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006;15:R271-R277.
17. Barnes JW, Tischkau SA, Barnes JA, et al. Requirement of mammalian timeless for circadian rhythmicity. Science 2003;302:439-442.
18. Sato TK, Yamada RG, Ukai H, et al. Feedback repression is required for mammalian circadian clock function. Nat Genet 2006;38:312-319.
19. Gallego M, Virshup DM. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 2007;8:139-148.
20. Roenneberg T, Merrow M. Circadian clocks-from genes to complex behavior. Reprod Nutr Dev 1999;39:277-294.
21. Hastings MH, Reddy AB, Maywood ES. A clockwork web: Circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003;4:649-661.
22. Moore-Ede MC, Czeisler CA, Richardson GS. Circadian timekeeping in health and disease. N Engl J Med 1983;309:469-476.
23. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001;93:1563-1568.
24. Mormont MC, Levi F. Circadian-system alternations during cancer processes: A review. Int J Cancer 1997;70:241-247.
25. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
26. Yeh KT, Yang MY, Liu TC, et al. Abnormal expression of Period 1 (PER1) in endometrial carcinoma. J Pathol 2005;206:111-120.
27. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005;26:1241-1246.
28. Shih HC, Choo KB, Chang TJ, et al. Disturbance of circadian gene expression in endometrial cancer; detection by real-time quantitative RT-PCR. Oncol Rep 2005;14:1533-1538.
29. Shih MC, Yeh KT, Tang KP, Chen JC, Chang JG. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. Mol Carcinog 2006;45:732-740.
30. Cedar H. DNA methylation and gene activity. Cell 1988;53:3-4.
31. Razin A. CpG methylation, chromatin structure and gene silencing - A three-way connection. EMBO J 1998;17:4905-4908.
32. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003;163:1101-1107.
33. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH. Aberrant CpG island hypermethylation along multiple hepatocarcinogenesis. Am J Pathol 2003;163:1371-1378.
34. Etchegaray J-P, Yang X, DeBruyne JP, et al. The polycomb group protein EZH2 is required for mammalian circadian clock function. J Biol Chem 2006;281:21209-21215.
35. Yang X, Downes M, Yu RT, et al. Nuclear receptor expression links the circadian clock to metabolism. Cell 2006;126:801-810.
36. Rutter J, Reick M, McKnight SL. Metabolism and the control of circadian rhythms. Annu Rev Biochem 2002;71:307-331.
37. Terazono H, Mutoh T, Yamaguchi S, et al. Adrenergic regulation of clock gene expression in mouse liver. Proc Natl Acad Sci USA 2003;100:6795-6800.
38. Balsalobre A, Brown SA, Marcacci L, et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000;289:2344-2347.
39. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the circadian clock in the liver by feeding. Science 2001;291:490-493.
40. Oster H, Werner C, Magnone MC, et al. cGMP-dependent protein kinase II modulates mPer1 and mPer2 gene induction and influences phase shifts of the circadian clock. Curr Biol 2003;13:725-733.
41. Masumoto KH, Fujioka A, Nakahama K, Inouye ST, Shigeyoshi Y. Effect of phosphodiesterase type 4 on circadian clock gene Per1 transcription. Biochem Biophys Res Commun 2003;306:781-785.
42. Motzkus D, Albrecht U, Maronde E. The human PER1 gene is inducible by interleukin-6. J Mol Neurosci 2002;18:105-109.
43. Motzkus D, Maronde E, Grunenberg U, Lee CC, Forssmann W, Albrecht U. The human PER1 gene is transcriptionally regulated by multiple signaling pathways. FEBS Lett 2000;486:315-319.
44. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003;302:255-259.
45. Storch KF, Lipan O, Leykin I, et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002;417:78-83.
46. Staels B. When the Clock stops ticking, metabolic syndrome explodes. Nat Med 2006;12:54-55.
47. Gillette MU, Sejnowski TJ. Physiology. Biological clocks coordinately keep life on time. Science 2005;309:1196-1198.
48. Zhu Y, Stevens RG, Leaderer D, et al. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 2008;107:421-425.
49. Zhu Y, Leaderer D, Guss C, et al. Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer 2007;120:432-435.